TREATMENT OF C-MYC/BCL2 DOUBLE EXPRESSER DLBCL WITH R-CHOP CHEMOIMMUNOTHERAPY: AN AUSTRALIAN SINGLE CENTRE EXPERIENCE
Version 2 2024-06-04, 00:11Version 2 2024-06-04, 00:11
Version 1 2021-10-21, 12:22Version 1 2021-10-21, 12:22
conference contribution
posted on 2024-06-04, 00:11 authored by TF Ng, A Whiteside, Hannah RoseHannah Rose, D Kipp, B Tawfik, P CampbellTREATMENT OF C-MYC/BCL2 DOUBLE EXPRESSER DLBCL WITH R-CHOP CHEMOIMMUNOTHERAPY: AN AUSTRALIAN SINGLE CENTRE EXPERIENCE
History
Volume
101Pagination
701-701Location
Copenhagen, DENMARKStart date
2016-06-09End date
2016-06-12ISSN
0390-6078Language
EnglishPublication classification
E3 Extract of paperTitle of proceedings
HAEMATOLOGICAEvent
21st Congress of the European-Hematology-AssociationPublisher
FERRATA STORTI FOUNDATIONUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC